Assessing Outpatient 'Day Procedure' for Second-trimester Medical Abortion at Two Public Sector Hospitals in Nepal

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

November 25, 2020

Primary Completion Date

August 31, 2021

Study Completion Date

August 31, 2021

Conditions
Abortion in Second Trimester
Interventions
DRUG

Mifepristone + Misoprostol

A single 200 mg mifepristone (one tablet) to be taken orally either at home or at the hospital, followed approximately 24 - 48 hours later with administration of 400 mcg misoprostol. Repeat doses of 400 mcg (two tablets) of misoprostol will be administered buccally (buccal) every three hours until the abortion is achieved.

Trial Locations (2)

Unknown

Bharatpur Hospital, Bharatpur

Lumbini Provincial Hospital, Butwāl

All Listed Sponsors
collaborator

KIST Medical College and Teaching Hospital

UNKNOWN

collaborator

Center for Research on Environment, Health and Population Activities

OTHER

collaborator

Bharatpur Eye Hospital

OTHER

collaborator

Lumbini Provincial Hospital

UNKNOWN

lead

Gynuity Health Projects

OTHER

NCT05046041 - Assessing Outpatient 'Day Procedure' for Second-trimester Medical Abortion at Two Public Sector Hospitals in Nepal | Biotech Hunter | Biotech Hunter